Vitamin D3 suppresses the cholesterol homeostasis pathway in patient-derived glioma cell lines.

Abstract

Glioblastoma is one of the most common malignant brain tumors. Vitamin D, primarily its hormonally active form Calcitriol, has been reported to have anti-cancer activity. Here, we used patient-derived glioma cell lines to examine the effect of Vitamin D3 and Calcitriol on glioblastoma. Surprisingly, Vitamin D3 showed a more significant inhibitory effect than Calcitriol on cell viability and proliferation. Vitamin D receptor (VDR) mediates most of vitamin D's cellular effects, and thus we examined the expression level and function of VDR via gene silencing and gene knockout experiments. We observed that VDR does not affect the sensitivity of patient-derived glioma cell lines to Vitamin D3, and the gene encoding VDR is not essential for growth of patient-derived glioma cell lines. RNA sequencing data analysis and sterolomics analysis revealed that Vitamin D3 inhibits cholesterol synthesis and cholesterol homeostasis by inhibiting the expression level of 7-dehydrocholesterol reductase, which leads to the accumulation of 7-dehydrocholesterol and other sterol intermediates. In conclusion, our results suggest that Vitamin D3, rather than Calcitriol, inhibits growth of patient-derived glioma cell lines via inhibition of the cholesterol homeostasis pathway.